Die USA sind der weltgrößte Markt für Medizinprodukte – und das macht diesen Markt gerade für die extrem export-orienteierten deutschen Hersteller interessant. Doch anders als in Europa ist dort eine Behörde für die Zulassung und Überwachung von Medizinprodukten zuständig, die Food and Drug Administration (FDA).
Medizintechnikunternehmen, die ihre Produkte in den USA vertreiben, sollten daher mit den FDA-Zulassungsverfahren und FDA-Inspektionen oder auch der 510(k) Premarket Notification vertraut sein. Für all jene, die hier noch Weiterbildungsbedarf haben, bietet die DeviceMed-Akademie auch 2019 wieder das passende Seminar:
Pain Management or Pain Medicine deals are devices that are used with only one goal in mind that is to ease or at times eliminate pain, to ease the suffering and improving the quality of life of those who are in pain. This branch of medicine includes a wide array of devices and various other branches of medicines that deal with psychologists, therapists and physiotherapists to name a few. Different sorts of pain types are dealt with different types of pain management devices and solutions. The most commonly used homemade remedy to cure pain is to apply heat and cold to the pain induced area. There are also common tablets which have no adverse side effects that can be consumed to relieve pain. Excluding these home remedies there are a variety of clinical remedies that include various devices, both electronic and mechanical to help relieve various kinds of pain.
The global pain management devices market is driven by technological advancements in the pain treatment and therapy arena, increasing patient awareness and health care expenditure, increasing prevalence of chronic and acute pain, and rising geriatric population are major factors driving the market. However, high cost related to pain management devices products is likely to restrain the market to certain extent.
Pain Management Devices Market Segment by Manufacturers, this report covers: Medtronic, ST. Jude Medical, Inc. (A subsidiary of Abbott), Boston Scientific Corporation, Hospira, Inc. (A subsidiary of Pfizer Inc.), Smiths Medical, B. Braun Melsungen AG, Halyard Health, Inc. (O&M Halyard or its affiliates) BIO-MEDICAL RESEARCH LTD, BD, and Nevro Corp. among others
Genotyping Assay or SNP (Single Nucleotide Polymorphism) genotyping is the measurement of how much genetic variation has taken place. Genotyping Assay is the most common of genetic variation. A SNP at the most basic level contains a specific locus, which contains two variants of any gene. Genotyping Assay technology is widely used in determining the sequence in DNA or genetic make-up by comparison with other sequence or reference sequence. Various methods are used to determine sequence in genotyping assay that includes PCR, DNA microarrays, RAPD among others. Various methods for Genotyping Assays include hybridization based methods and Enzyme based methods. An advanced version of DNA sequencing is said to be Next Generation Sequencing.
The prominent players in the global Genotyping Assay market are Agilent Technologies, Thermo Fisher Scientific, Illumina, QIAGEN N.V., Danaher Corporation, Eurofins Scientific, F. Hoffmann-La Roche, GE Healthcare, PerkinElmer, and GENEWIZ, among others.
Stem Cell assay are analytical procedures that are used in various medical and biological fields such as laboratory medicine, pharmacology, environmental biology and molecular biology for the sole purpose of qualitative assessment and measurement, amount and ability of an analyte. Analyte can be a drug, a biochemical substance or even a simple cell in any organism. The measured entity is referred to as an analyte. Stem Cells assays are a fundamental part of modern environmental, pharmaceutical, forensic and many other various business models from industrial to many other curbside level businesses. Any Stem cell assay are processed and prepared in the following steps, namely, sample preparation and manipulation, Target specific discrimination, Signal amplification of the sample, Signal Detection with Signal enhancement or noise filtering as the last manner. Result of any stem cell assays can differ from qualitative assays to semi-qualitative assays and from quantitative assays to functional assays.
Worldwide Knee Replacement 2019 Research Report presents a professional and complete analysis of Global Knee Replacement Market on the current situation.
The recent report, Knee Replacement market fundamentally discovers insights that enable stakeholders, business owners and field marketing executives to make effective investment decisions driven by facts – rather than guesswork. The study aims at listening, analyzing and delivering actionable data on the competitive landscape to meet the unique requirements of the companies and individuals operating in the Knee Replacement market for the forecast period, 2019 to 2025. To enable firms to understand the Knee Replacement industry in various ways the report thoroughly assesses the share, size and growth rate of the business worldwide.